Diane Descamps
Diane Descamps
Professor of Medicine, Virology Dpt, Paris-Diderot University, Bichat hospital, Paris
Verified email at
Cited by
Cited by
Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ...
Emerging infectious diseases 26 (7), 1478, 2020
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
FX Lescure, L Bouadma, D Nguyen, M Parisey, PH Wicky, S Behillil, ...
The Lancet Infectious Diseases 20 (6), 697-706, 2020
Evidence of sexual transmission of Zika virus
E D’Ortenzio, S Matheron, X de Lamballerie, B Hubert, G Piorkowski, ...
New England Journal of Medicine 374 (22), 2195-2198, 2016
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
D Descamps, P Flandre, V Calvez, G Peytavin, V Meiffredy, G Collin, ...
Jama 283 (2), 205-211, 2000
Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy
JJ Parienti, V Massari, D Descamps, A Vabret, E Bouvet, B Larouzé, ...
Clinical Infectious Diseases 38 (9), 1311-1316, 2004
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial
JL Meynard, M Vray, L Morand-Joubert, E Race, D Descamps, G Peytavin, ...
Aids 16 (5), 727-736, 2002
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results …
Y Yazdanpanah, C Fagard, D Descamps, AM Taburet, C Colin, ...
Clinical Infectious Diseases 49 (9), 1441-1449, 2009
Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome
V Descamps, F Bouscarat, S Laglenne, E Aslangul, B Veber, D Descamps, ...
British Journal of Dermatology 137 (4), 605-608, 1997
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses
D Descamps, G Collin, F Letourneur, C Apetrei, F Damond, ...
Journal of virology 71 (11), 8893-8898, 1997
SARS-CoV-2 specific antibody responses in COVID-19 patients
NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ...
MedRxiv, 2020
Zika virus in the female genital tract
N Prisant, L Bujan, H Benichou, PH Hayot, L Pavili, S Lurel, C Herrmann, ...
The Lancet infectious diseases 16 (9), 1000-1001, 2016
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C
A Desnoyer, D Pospai, MP Lê, A Gervais, A Heurgué-Berlot, A Laradi, ...
Journal of hepatology 65 (1), 40-47, 2016
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ...
Science translational medicine 12 (559), eabc3103, 2020
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy
AJ Hance, V Lemiale, J Izopet, D Lecossier, V Joly, P Massip, ...
Journal of virology 75 (14), 6410-6417, 2001
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss
E Dam, R Quercia, B Glass, D Descamps, O Launay, X Duval, ...
PLoS pathogens 5 (3), e1000345, 2009
Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
D Descamps, C Apetrei, G Collin, F Damond, F Simon, F Brun-Vezinet
Aids 12 (9), 1109-1111, 1998
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma
R Schuurman, D Descamps, GJ Weverling, S Kaye, J Tijnagel, I Williams, ...
Journal of clinical microbiology 34 (12), 3016-3022, 1996
The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection
A Bergamaschi, D Ayinde, A David, E Le Rouzic, M Morel, G Collin, ...
Journal of virology 83 (10), 4854-4860, 2009
The system can't perform the operation now. Try again later.
Articles 1–20